現代牙科(03600.HK)前9月銷量總數(北美除外)01.81萬件 同比增長6.4%
格隆匯11月29日丨現代牙科(03600.HK)公佈,截至2019年9月30日止九個月,集團的銷量總數(北美除外)約為101.81萬件,增加約6.4%。
截至2019年9月30日止九個月,集團的收益總額(北美除外)較截至2018年9月30日止九個月增加約1.9%。由於持續集中推廣高價值產品及取締低價值項目,北美市場的銷售於截至2019年9月30日止九個月上升2.2%。集團喜見銷售情況好轉的跡象,此乃直接由於集團於北美市場不斷整合並實施新策略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.